REPLIMUNE GROUP, INC.

REPL ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2026

Total Assets: $332.4M

Liabilities Breakdown FY2026

Total Liabilities: $166.2M